Sign In
Buy EBS
$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
Monkeypox Stocks BVNRY, EBS, CMRX, SIGA Heat Up on U.S. Vaccine Stockpile
10:38am, Wednesday, 29'th Jun 2022
Stocks related to the treatment of monkeypox are heating up today on news that the U.S. is building a vaccine stockpile and will offer vaccine appointments to individuals who are at risk of contractin
Emergent's (EBS) Anthrax Vaccine BLA Gets FDA Acceptance
02:31pm, Monday, 27'th Jun 2022 Zacks Investment Research
The FDA accepts Emergent's (EBS) BLA seeking approval for its new anthrax vaccine, AV7909. A decision is expected in April next year.
Emergent's (EBS) Anthrax Vaccine BLA Gets FDA Acceptance
12:19pm, Monday, 27'th Jun 2022
The FDA accepts Emergent's (EBS) BLA seeking approval for its new anthrax vaccine, AV7909. A decision is expected in April next year.
Emergent BioSolutions Announces FDA Acceptance of Biologics License Application for AV7909 Anthrax Vaccine Candidate
10:30am, Friday, 24'th Jun 2022 GlobeNewswire Inc.
GAITHERSBURG, Md., June 24, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that the U.S. Food and Drug Administration (FDA) accepted for review the Biologics License
Emergent BioSolutions says FDA has accepted its anthrax vaccine candidate for review
06:39am, Friday, 24'th Jun 2022
Emergent BioSolutions Inc. EBS, +7.19% said Friday the U.S. Food and Drug Administration has accepted for review its application for approval of its anthrax vaccine. Dubbed AV7909, the vaccine is aime
Emergent BioSolutions Announces Publication of CHIKV VLP Phase 2 Safety and Immunogenicity Data in The Lancet Infectious Diseases
10:30am, Tuesday, 21'st Jun 2022 GlobeNewswire Inc.
GAITHERSBURG, Md., June 21, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that two-year persistence data from its phase 2 clinical study evaluating the safety and im
Two Pharma Companies That Will Profit From The MonkeyPox Outbreak
11:30am, Sunday, 12'th Jun 2022
The monkeypox outbreak has affected 780 people since identified on May 13, 2022. Vaccines are key to curtailing the spread of Monekey Pox. Two pharma companies, Geovax Labs Inc. and Emergent Biosoluti
7 No-Brainer Biotech Stocks to Add to Your Buy List
09:58am, Thursday, 09'th Jun 2022
With the broader markets grumbling, investors should consider biotech stocks to buy for their permanently relevant profile. The post 7 No-Brainer Biotech Stocks to Add to Your Buy List appeared first
7 Monkeypox Stocks That May Take Off in Q2
06:28am, Thursday, 09'th Jun 2022
SIGA Technologies (SIGA) may lead on the list of monkeypox stocks that could soar, but Bavarian Nordic seems to be leading the sales race. The post 7 Monkeypox Stocks That May Take Off in Q2 appeared
Emergent (EBS) Stock Down as J&J Ends COVID-19 CDMO Contract
01:07pm, Tuesday, 07'th Jun 2022 Zacks Investment Research
Emergent (EBS) sends contract breach notice to J&J, following the latter's decision to end their contract for CDMO services for its COVID-19 vaccine. J&J also cites contract breach as the basis for te
J&J Serves Notice To Emergent For Terminating COVID-19 Shot Contract As Two Accuse Each Other Of Breach Of Agreement
11:33am, Tuesday, 07'th Jun 2022 Benzinga
Johnson & Johnson (NYSE: JNJ) has made another move towards severing its Covid-19 vaccine manufacturing ties with contract manufacturer Emergent Biosolutions, Inc. (NYSE: EBS).
What Happened: J&J has
Emergent (EBS) Stock Down as J&J Ends COVID-19 CDMO Contract
10:32am, Tuesday, 07'th Jun 2022
Emergent (EBS) sends contract breach notice to J&J, following the latter's decision to end their contract for CDMO services for its COVID-19 vaccine. J&J also cites contract breach as the basis for te
Contract manufacturer Emergent says J&J breached vaccine contract
09:01am, Monday, 06'th Jun 2022
Contract manufacturer Emergent BioSolutions Inc said on Monday U.S. drugmaker Johnson & Johnson had breached an agreement by failing to buy the minimum quantity of COVID-19 vaccines made by the compan
Deciphera Pharmaceuticals, Inc. (DCPH) Up 4.3% Since Last Earnings Report: Can It Continue?
03:31pm, Friday, 03'rd Jun 2022 Zacks Investment Research
Deciphera Pharmaceuticals, Inc. (DCPH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Emergent BioSolutions to Participate in Investor Conferences
12:20pm, Thursday, 02'nd Jun 2022 GlobeNewswire Inc.
GAITHERSBURG, Md., June 02, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the followin
